← Leaderboards
Conor C Lynch
H. Lee Moffitt Cancer Ctr & Res Inst
$9,082,731
Attributed
$12,365,128
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,365,128 · 9
By mechanism
R01$5,876,575 · 4
U01$5,543,618 · 2
P30$544,280 · 2
R21$400,655 · 1
Top collaborators
- David Basanta Gutierrez11 shared
- Lori A Hazlehurst2 shared
Most similar at H. Lee Moffitt Cancer Ctr & Res Inst
Same institution · by research overlap
- David Basanta Gutierrez$3,082,070
Others in their field
Top investigators on “Growth”
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$233,131,631
- Albert Lazzarini · California Institute Of Technology$170,110,000
- David H Reitze · University Of Florida$170,110,000
- Garret A Fitzgerald · University Of Pennsylvania$153,184,124
- David Heimbrook · Leidos Biomedical Research, Inc.$143,966,408
- Carol Nesel · Westat$116,355,411
Research focus
GrowthBoneOsteoclastsOsteoblastsResponseCellsBaseIn VivoDisease ProgressionOsteolysisAutomobile DrivingIn VitroInnovationCell LineInsightBone NeoplasmsHuman DiseaseMalignant NeoplasmsBone DiseasesStandard Of CarePainBone CellBiologicalMonitor
Grant awards (31)
An integrated mathematical modeling approach to define how the aging bone ecosystem drives multiple myeloma evolution and treatment response$620,521
R01 · FY2025 · CA · contact PI
Role of ULK3 in Sensitive and Refractory Multiple Myeloma$534,381
R01 · FY2025 · CA · contact PI
Role of ULK3 in Sensitive and Refractory Multiple Myeloma$508,992
R01 · FY2024 · CA · contact PI
Defining bone ecosystem effects on metastatic prostate cancer evolution and treatment response using an integrated mathematical modeling approach$442,936
U01 · FY2024 · CA · contact PI
Role of ULK3 in Sensitive and Refractory Multiple Myeloma$537,178
R01 · FY2023 · CA · contact PI
Defining bone ecosystem effects on metastatic prostate cancer evolution and treatment response using an integrated mathematical modeling approach$477,037
U01 · FY2023 · CA · contact PI
Local and systemic control of multiple myeloma colonization and growth by MMP-13$431,631
R01 · FY2023 · CA · contact PI
Tissue Core$1
P30 · FY2023 · CA · contact PI
Local and systemic control of multiple myeloma colonization and growth by MMP-13$431,630
R01 · FY2022 · CA · contact PI
Defining bone ecosystem effects on metastatic prostate cancer evolution and treatment response using an integrated mathematical modeling approach$323,155
U01 · FY2022 · CA · contact PI
Tissue Core$162,193
P30 · FY2022 · CA · contact PI
Defining bone ecosystem effects on metastatic prostate cancer evolution and treatment response using an integrated mathematical modeling approach$515,073
U01 · FY2021 · CA · contact PI
Local and systemic control of multiple myeloma colonization and growth by MMP-13$440,438
R01 · FY2021 · CA · contact PI
Tissue Core$188,792
P30 · FY2021 · CA · contact PI
Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer$637,735
U01 · FY2020 · CA
Defining bone ecosystem effects on metastatic prostate cancer evolution and treatment response using an integrated mathematical modeling approach$520,437
U01 · FY2020 · CA · contact PI
Local and systemic control of multiple myeloma colonization and growth by MMP-13$440,438
R01 · FY2020 · CA · contact PI
Tissue Core$188,796
P30 · FY2020 · CA · contact PI
Tissue Core$4,498
P30 · FY2020 · CA · contact PI
Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer$581,609
U01 · FY2019 · CA
Local and systemic control of multiple myeloma colonization and growth by MMP-13$458,439
R01 · FY2019 · CA · contact PI
Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer$668,427
U01 · FY2018 · CA
Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer$690,824
U01 · FY2017 · CA
Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer$686,385
U01 · FY2016 · CA
Specific skeletal targeting of MMP-2 for the treatment of multiple myeloma$180,762
R21 · FY2016 · CA · contact PI
Specific skeletal targeting of MMP-2 for the treatment of multiple myeloma$219,893
R21 · FY2015 · CA · contact PI
Host MMP-mediated regulation of the vicious cycle of prostate to bone metastases$292,017
R01 · FY2014 · CA · contact PI
Host MMP-mediated regulation of the vicious cycle of prostate to bone metastases$283,026
R01 · FY2013 · CA · contact PI
Host MMP-mediated regulation of the vicious cycle of prostate to bone metastases$305,904
R01 · FY2012 · CA · contact PI
Host MMP-mediated regulation of the vicious cycle of prostate to bone metastases$302,517
R01 · FY2011 · CA · contact PI
Host MMP-mediated regulation of the vicious cycle of prostate to bone metastases$289,463
R01 · FY2010 · CA · contact PI